<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2022/12/leon-bredella-xj2ag2lp5eq-unsplash-scaled.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="2560" height="1920" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2022/12/leon-bredella-xj2ag2lp5eq-unsplash-scaled.jpg"/></p>
<p>“道琼斯狗” 策略重新回归，Capital Wealth Planning 的 Kevin Simpson 认为 2026 年可能是另一个强劲的年份。</p>
<p>在 2025 年获得 17% 的收益，超越了更广泛的道琼斯表现，Simpson 将目光锁定在他认为对以收入为重点的投资者至关重要的三个名字上：安进、威瑞森和家得宝。</p>
<p>这三家公司各有不同的优势：从医疗保健的韧性到高收益股息和周期性复苏潜力。</p>
<p>这三家公司共同代表了股息投资者在进入一个稳定性和现金流比追求增长更为重要的年份时所渴望的平衡。</p>
<h2>安进股票：医疗保健的实力与稳定的股息</h2>
<p>安进股票已成为 Simpson 在 2026 年 “道琼斯狗” 中的首选之一。</p>
<p>这家生物技术巨头以其在肿瘤学和免疫学领域的治疗组合而闻名，既为投资者提供了防御性特质，又提供了可靠的收入。</p>
<p>Simpson 指出，医疗保健交易 “在 2025 年底真正开始活跃”，而安进正处于受益于这一势头的位置。</p>
<p>凭借 3.08% 的稳定股息收益率和持续派息的良好记录，这家纳斯达克上市公司为市场波动提供了缓冲。</p>
<p>对于那些寻求医疗创新同时又优先考虑收入的投资者来说，AMGN 在增长潜力和稳定性之间脱颖而出。</p>
<h2>威瑞森股票：高收益的收入投资者支柱</h2>
<p>对于那些将收益置于首位的投资者，Simpson 指出威瑞森股票是一个常青的选择。</p>
<p>“如果你是一个股息投资者，VZ 总是似乎位居榜单之首，” 他说，强调该公司在撰写时接近 7% 的收益率。</p>
<p>尽管威瑞森的增长前景温和，但其缓慢的股价实际上转化为可靠的现金回报。</p>
<p>这家电信巨头的前瞻市盈率为 8.5，突显了其价值导向，使其对希望获得可预测收入而非快速增值的投资者具有吸引力。</p>
<p>在一个波动性可能侵蚀信心的市场中，VZ 股票的稳定派息起到了稳定作用。对于股权收入投资组合而言，它仍然是 2026 年最可靠的 “道琼斯狗” 之一。</p>
<h2>家得宝股票：显著的周期性反弹潜力</h2>
<p>在 “道琼斯狗” 新成员中，家得宝股票是 Simpson 在 2026 年的突出想法。</p>
<p>它在 2025 年表现不佳，下降了 11%，但这位市场老将相信，如果利率开始正常化，这家家居改善零售商可能会出现显著反弹。</p>
<p>凭借其强大的品牌和主导市场地位，HD 股票在住房和消费者支出周期性上升中处于良好位置。</p>
<p>Simpson 强调了其潜力，指出借贷成本的正常化可能会重新点燃对家庭装修项目的需求。</p>
<p>对于愿意超越短期疲软的投资者，家得宝提供了股息吸引力（2.66% 的收益率）和与更广泛经济复苏相关的上行空间。</p>
<p>这篇文章首次出现在 Invezz 上，标题为 “这三只 ‘道琼斯狗’ 股票是 2026 年必备的”</p>

威瑞森

安进

家得宝

<p>凯文·辛普森（Kevin Simpson）来自资本财富规划（Capital Wealth Planning），他为 2026 年推荐了三只 “道琼斯狗” 股票：安进（Amgen）、威瑞森（Verizon）和家得宝（Home Depot）。安进提供了 3.08% 的股息收益率，展现出医疗保健的韧性，是收入导向投资者的稳健选择。威瑞森的收益率接近 7%，尽管增长温和，但因其可靠的现金回报而受到青睐。尽管家得宝近期有所下滑，但如果利率正常化，预计将有显著的反弹潜力，提供 2.66% 的收益率，并与经济复苏相关联。这些股票在 2026 年被推荐用于稳定性和收入</p>

<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2022/12/leon-bredella-xj2ag2lp5eq-unsplash-scaled.jpg" alt="" original-src="https://invezz.com/wp-content/uploads/2022/12/leon-bredella-xj2ag2lp5eq-unsplash-scaled.jpg"/></p>
<p>The “Dogs of the Dow” strategy has staged a comeback, and Kevin Simpson of Capital Wealth Planning believes 2026 could be another strong year.</p>
<div class="lb-trans"><p>“道琼斯狗” 策略重新回归，Capital Wealth Planning 的 Kevin Simpson 认为 2026 年可能是另一个强劲的年份。</p>
</div><p>After a 17% gain in 2025, beating the broader Dow’s performance, Simpson is zeroing in on three names he sees as essential for income-focused investors: Amgen, Verizon, and Home Depot.</p>
<div class="lb-trans"><p>在 2025 年获得 17% 的收益，超越了更广泛的道琼斯表现，Simpson 将目光锁定在他认为对以收入为重点的投资者至关重要的三个名字上：安进、威瑞森和家得宝。</p>
</div><p>Each offers a different angle: from healthcare resilience to high-yield dividend and cyclical recovery potential.</p>
<div class="lb-trans"><p>这三家公司各有不同的优势：从医疗保健的韧性到高收益股息和周期性复苏潜力。</p>
</div><p>Together, these three names represent the kind of balance that dividend investors crave heading into a year where stability and cash flow will matter more than chasing growth.</p>
<div class="lb-trans"><p>这三家公司共同代表了股息投资者在进入一个稳定性和现金流比追求增长更为重要的年份时所渴望的平衡。</p>
</div><h2>Amgen stock: healthcare strength with steady dividends</h2>
<div class="lb-trans"><h2>安进股票：医疗保健的实力与稳定的股息</h2>
</div><p>Amgen stock has emerged as one of Simpson’s top picks within the “Dogs of the Dow” for 2026.</p>
<div class="lb-trans"><p>安进股票已成为 Simpson 在 2026 年 “道琼斯狗” 中的首选之一。</p>
</div><p>The biotech giant – known for its portfolio of treatments in oncology and immunology – offers investors both defensive qualities and reliable income.</p>
<div class="lb-trans"><p>这家生物技术巨头以其在肿瘤学和免疫学领域的治疗组合而闻名，既为投资者提供了防御性特质，又提供了可靠的收入。</p>
</div><p>Simpson noted that the healthcare trade “really started to come to life at the end of 2025,” and Amgen is positioned to benefit from that momentum.</p>
<div class="lb-trans"><p>Simpson 指出，医疗保健交易 “在 2025 年底真正开始活跃”，而安进正处于受益于这一势头的位置。</p>
</div><p>With a solid dividend yield of 3.08% and a track record of consistent payouts, the Nasdaq-listed firm provides a cushion against market volatility.</p>
<div class="lb-trans"><p>凭借 3.08% 的稳定股息收益率和持续派息的良好记录，这家纳斯达克上市公司为市场波动提供了缓冲。</p>
</div><p>For investors seeking exposure to healthcare innovation while still prioritizing income, AMGN stands out as a blend of growth potential and stability.</p>
<div class="lb-trans"><p>对于那些寻求医疗创新同时又优先考虑收入的投资者来说，AMGN 在增长潜力和稳定性之间脱颖而出。</p>
</div><h2>Verizon stock: a high-yield anchor for income investors</h2>
<div class="lb-trans"><h2>威瑞森股票：高收益的收入投资者支柱</h2>
</div><p>For those prioritizing yield above all else, Simpson points to Verizon stock as a perennial favorite.</p>
<div class="lb-trans"><p>对于那些将收益置于首位的投资者，Simpson 指出威瑞森股票是一个常青的选择。</p>
</div><p>“If you’re a dividend player, VZ always seems to top that list,” he said, highlighting the company’s nearly 7% yield at the time of writing.</p>
<div class="lb-trans"><p>“如果你是一个股息投资者，VZ 总是似乎位居榜单之首，” 他说，强调该公司在撰写时接近 7% 的收益率。</p>
</div><p>While Verizon’s growth prospects are modest, its slow-moving stock price actually translates into dependable cash returns.</p>
<div class="lb-trans"><p>尽管威瑞森的增长前景温和，但其缓慢的股价实际上转化为可靠的现金回报。</p>
</div><p>The telecom giant’s forward multiple of 8.5 underscores its value orientation, making it attractive for investors who want predictable income rather than rapid appreciation.</p>
<div class="lb-trans"><p>这家电信巨头的前瞻市盈率为 8.5，突显了其价值导向，使其对希望获得可预测收入而非快速增值的投资者具有吸引力。</p>
</div><p>In a market where volatility can erode confidence, VZ shares’ steady payouts act as a stabilizing force. For equity income portfolios, it remains one of the most reliable “Dogs of the Dow” in 2026.</p>
<div class="lb-trans"><p>在一个波动性可能侵蚀信心的市场中，VZ 股票的稳定派息起到了稳定作用。对于股权收入投资组合而言，它仍然是 2026 年最可靠的 “道琼斯狗” 之一。</p>
</div><h2>Home Depot stock: significant cyclical rebound potential</h2>
<div class="lb-trans"><h2>家得宝股票：显著的周期性反弹潜力</h2>
</div><p>Among the newcomers to the Dogs lineup, Home Depot stock is Simpson’s standout idea for 2026.</p>
<div class="lb-trans"><p>在 “道琼斯狗” 新成员中，家得宝股票是 Simpson 在 2026 年的突出想法。</p>
</div><p>It has struggled in 2025, falling 11%, but the market veteran believes that if interest rates begin to normalize, the home improvement retailer could stage a significant rebound.</p>
<div class="lb-trans"><p>它在 2025 年表现不佳，下降了 11%，但这位市场老将相信，如果利率开始正常化，这家家居改善零售商可能会出现显著反弹。</p>
</div><p>With its strong brand and dominant market position, HD shares are well-positioned to benefit from a cyclical upswing in housing and consumer spending.</p>
<div class="lb-trans"><p>凭借其强大的品牌和主导市场地位，HD 股票在住房和消费者支出周期性上升中处于良好位置。</p>
</div><p>Simpson underscored its potential, noting that normalization in borrowing costs could reignite demand for home renovation projects.</p>
<div class="lb-trans"><p>Simpson 强调了其潜力，指出借贷成本的正常化可能会重新点燃对家庭装修项目的需求。</p>
</div><p>For investors willing to look past short-term weakness, Home Depot offers both dividend appeal (2.66% yield) and upside tied to broader economic recovery.</p>
<div class="lb-trans"><p>对于愿意超越短期疲软的投资者，家得宝提供了股息吸引力（2.66% 的收益率）和与更广泛经济复苏相关的上行空间。</p>
</div><p>The post These three 'Dogs of the Dow' stocks are must-own for 2026 appeared first on Invezz</p>
<div class="lb-trans"><p>这篇文章首次出现在 Invezz 上，标题为 “这三只 ‘道琼斯狗’ 股票是 2026 年必备的”</p>
</div>

这三只 ‘道琼斯的狗’ 股票是 2026 年必买的